Skip to main content

CORRECTION article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1548247

Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T (CAR-T) cells targeting CEA-positive carcinoma

Provisionally accepted
Chengcheng Zhang Chengcheng Zhang 1,2Linling Wang Linling Wang 3Qianzhen Zhang Qianzhen Zhang 3Junjie Shen Junjie Shen 3Xia Huang Xia Huang 3Meiling Wang Meiling Wang 3Yi Huang Yi Huang 3Jun Chen Jun Chen 3Yanmin Xu Yanmin Xu 3Wenxu Zhao Wenxu Zhao 3Yanan Qi Yanan Qi 3Yunyan Li Yunyan Li 3Yanjiao Ou Yanjiao Ou 1Yang Zhi Yang Zhi 3Cheng Qian Cheng Qian 3*
  • 1 Southwest Hospital, Army Medical University, Chongqing, China
  • 2 Army Medical University, Chongqing, China
  • 3 Chongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd, Chongqing, China

This article is a correction to:

  1. Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma

    1. Read original article

The final, formatted version of the article will be published soon.

    In the published article, there was an error in Figure 7A as published. Among a large amount of pictures for selection, we found two graphs identical since they were not classified correctly. The corrected Figure 7A and its caption appear below.

    Keywords: chimeric antigen receptor T cells, Carcinoembryonic Antigen, Single-chain fragment variable, Affinity, cell therapy

    Received: 19 Dec 2024; Accepted: 10 Jan 2025.

    Copyright: © 2025 Zhang, Wang, Zhang, Shen, Huang, Wang, Huang, Chen, Xu, Zhao, Qi, Li, Ou, Zhi and Qian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Cheng Qian, Chongqing Key Laboratory of Gene and Cell Therapy, Institute of Precision Medicine and Biotechnology, Chongqing Precision Biotech Co. Ltd, Chongqing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.